Porte drug repurposing dataset for epilepsy

Version 1.0.0 (05/26/2023) This is a drug repurposing dataset on epilepsy, compiled by Dr. Baptiste PORTE &lt;[e-mail]&gt; in January 2021 at Inserm UMR 1141 Neurodiderot, 48 boulevard Sérurier, F-75019 Paris, France. Its author has authorized the publication under the MIT licence of this dataset by Clémence Réda from the RECeSS project (Grant ID 101102016) on May 20th, 2023. It consists in two .CSV files: 1. Liste anticonvu.csv with 6 columns "Compound CID": Best match PubChem CID for the considered chemical compound<br> "drug_name": The common drug name<br> "score": preliminary drug class in {0: unknown effect on epileptic patients, 1: antiepileptic drug, that is, treatment for epileptic patients}<br> "verification": 1st bibliographic round for drug class in {0: unknown effect on epileptic patients, 1: antiepileptic drug, that is, treatment for epileptic patients}<br> "verif 2": final assigned drug class in {0: unknown effect on epileptic patients, 1: antiepileptic drug, that is, treatment for epileptic patients}<br> "details": justification -in French- for the final assigned drug class 2. Liste proconvu.csv "Compound CID": Best match PubChem CID for the considered chemical compound<br> "drug_name": The common drug name<br> "score": preliminary drug class in {0: unknown effect on epileptic patients, -1: proconvulsant drug, that is, seizure-inducing}<br> "verification": 1st bibliographic round for drug class in {0: unknown effect on epileptic patients, -1: proconvulsant drug, that is, seizure-inducing}<br> "verif 2": final assigned drug class in {0: unknown effect on epileptic patients, -1: proconvulsant drug, that is, seizure-inducing}<br> "effet convulsivant demontré": justification -in French- for the final assigned drug class For any questions, please contact the author at &lt;[e-mail]&gt; or the RECeSS project contributors at &lt;[e-mail]&gt;.